Léim ar aghaidh chuig an bpríomhábhar
Gnáthamharc

Medicinal Products

Dáil Éireann Debate, Thursday - 26 February 2026

Thursday, 26 February 2026

Ceisteanna (550)

Ken O'Flynn

Ceist:

550. Deputy Ken O'Flynn asked the Minister for Health the estimated number of adults nationally who meet the clinical eligibility thresholds outlined in the completed HTAs for tirzepatide for diabetes and weight management indications; the estimated number of adolescents who would meet the subpopulation criteria proposed for semaglutide reimbursement; whether her Department has been advised of projected uptake rates; and if she will make a statement on the matter. [15880/26]

Amharc ar fhreagra

Freagraí scríofa

Under the Health (Pricing and Supply of Medical Goods) Act 2013, the HSE has statutory responsibility for decisions on the pricing and reimbursement of medicines and medical devices; therefore, the matter has been referred to the HSE for attention and direct reply to the Deputy.

Roinn